1. Inflammatory markers in patients after hematopoietic stem cell transplantation.
- Author
-
Sjøqvist C and Snarski E
- Subjects
- Biomarkers blood, C-Reactive Protein metabolism, Calcitonin blood, Calcitonin Gene-Related Peptide, Communicable Diseases blood, Communicable Diseases diagnosis, Graft vs Host Disease blood, Graft vs Host Disease immunology, Humans, Inflammation blood, Inflammation diagnosis, Lung Diseases blood, Lung Diseases immunology, Mucositis blood, Mucositis immunology, Predictive Value of Tests, Protein Precursors blood, Risk Factors, Time Factors, Transplantation Conditioning adverse effects, Treatment Outcome, Communicable Diseases immunology, Hematopoietic Stem Cell Transplantation adverse effects, Inflammation immunology, Inflammation Mediators blood
- Abstract
Infections are one of the most common complications after hematopoietic stem cell transplantation (HSCT). Diagnosis is established by analysis of clinical symptoms and results of diagnostic tests such as biochemical panels, microbiological cultures, and visual diagnostics. As the microbiological cultures yield positive results in only some patients and visual diagnostics might miss the infectious source, the diagnosis and proper treatment often depends on clinical assessment supported by laboratory test results. The most commonly used makers of inflammation include C-reactive protein and procalcitonin. However, these tests have serious limitations when used in patients after HSCT. The drugs used in conditioning, neutropenia, and graft-versus-host disease might influence the results of the tests and misguide the physician. In this review, we summarize the current knowledge on profiles of expression of basic markers of inflammation used in clinical practice in patients after HSCT.
- Published
- 2013
- Full Text
- View/download PDF